Tucuvi, a Madrid-based HealthTech company innovating certified voice AI, raised €17 million ($20 million) in Series A funding to accelerate the adoption of its AI-based care management platform in healthcare systems.
The round was led by Cathay Innovation and Kfund, through its early-growth fund Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling.
“Healthcare is under enormous pressure, and partial solutions are no longer enough,” explains María González, CEO of Tucuvi. “To continue providing quality care at scale, healthcare systems need AI they can trust: secure, auditable, and designed for real clinical environments. We are proud to already be working with more than 60 healthcare organisations and continue to grow to meet increasing demand.” (Translated).
Tucuvi’s Series A round can be situated within a wider, still relatively selective flow of European capital into AI-driven healthcare platforms during 2025–2026.
In early 2025, Warsaw-based primary care startup Jutro Medical raised €12 million in a Series A round to expand its network of physical clinics and deploy medical AI agents across telemedicine and operational workflows. This was followed later in the year by a €24 million Series A extension, also reported by EU-Startups, to further scale its AI-first primary care model and automation capabilities across clinical and administrative functions.
Against this backdrop, Tucuvi’s Madrid-based focus on certified voice AI and end-to-end care management workflows reflects a parallel approach to addressing workforce shortages and care complexity, albeit through software deployed directly into existing healthcare systems rather than through direct care delivery.
Taken together, the roughly €53 million raised across these announcements points to a growing, though still concentrated, level of investment in European healthcare AI companies seeking to increase care capacity and operational efficiency through automation.
“The Tucuvi platform transforms protocols and clinical guidelines into real, reliable, and consistent AI workflows, allowing us to interact with all our patients and enabling our nursing team to devote their expertise to cases that require high-value clinical judgment,” adds an unidentified Medical Director. (Translated).
Healthcare systems are facing increasing pressure from a shortage of professionals, rising demand for care, and greater operational complexity. Tucuvi was founded in 2019 to respond to this context with secure, auditable, and autonomous AI agents that aim to expand care capacity without compromising clinical quality or trust.
The company has developed an AI-powered Care Management platform designed to automate and orchestrate high-volume care workflows from start to finish.
The platform is based on AI agents, including LOLA, a voice-based AI agent that conducts secure phone conversations with patients, executes clinical and care coordination workflows, and escalates to human teams when necessary.
Tucuvi currently supports more than 50 workflows, ranging from post-surgical follow-up and discharge to chronic disease management, preoperative assessments, test preparation, screening programs, appointment scheduling, and demand management.
Tucuvi’s voice AI agents handle phone interactions, while the platform as a whole takes care of workflow logic, referrals, documentation, and integration with existing healthcare system operations.
“What convinced us at Cathay Innovation is Tucuvi’s ability to combine clinical rigor, regulatory credibility, and real-world scalability in a single platform,” said Jacky Abitbol, Managing Partner at Cathay Innovation. “Its approach allows healthcare organisations to deploy autonomous AI with confidence, freeing up significant capacity for care teams while maintaining the highest levels of safety and quality. We believe Tucuvi is blazing a new trail in how AI can be responsibly integrated into healthcare operations.”
Tucuvi is reportedly the first AI platform to obtain European regulatory approval as a Class IIb Software as a Medical Device (SaMD) for both its voice agent and patient management platform.
The company outlines that their platform has generated consistent and measurable results in collaborating healthcare systems, including:
- Up to 80% automation of nursing follow-up flows
- Patient reach and adherence greater than 90%, even in highly complex populations
- Improved outcomes in chronic diseases, such as a 5.5% reduction in readmissions for COPD
With this funding, Tucuvi will accelerate its growth strategy in Europe and the United States, expand its AI capabilities, and continue to evolve its platform as a comprehensive action and intelligence system for care teams.
Read the orginal article: https://www.eu-startups.com/2026/01/spains-healthtech-startup-tucuvi-raises-e17-million-to-scale-lola-voice-ai-reporting-up-to-80-automation-in-nursing-follow-up/
